CONMED Corporation
DE ˙ DB ˙ US2074101013
29,80 € ↑1,40 (4,93%)
2026-06-04
AKTIENPREIS
SecurityDE:EC8 / CONMED Corporation
InstitutionRockefeller Capital Management L.P.
Latest Disclosed Ownership1,388 shares
Latest Disclosed Value $ 49,113
Rockefeller Capital Management L.P. reports 33.08% increase in ownership of EC8 / CONMED Corporation

On May 14, 2026 - Rockefeller Capital Management L.P. filed a 13F-HR form disclosing ownership of 1,388 shares of CONMED Corporation (DE:EC8) valued at $42,473 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on March 16, 2026 disclosing 1,043 shares of CONMED Corporation. This represents a change in shares of 33.08% during the quarter. The current value of the position is $41,362 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F CONMED COM 207410101 1,388 345 33.08 49 16.67 0.0001
2026-03-16 2025-12-31 13F/A-1 CONMED COM 207410101 1,043 341 48.58 42 27.27 0.0001
2026-02-14 2025-12-31 13F CONMED COM 207410101 1,044 342 42 0.0000
2025-11-14 2025-09-30 13F CONMED COM 207410101 702 702 33 0.0001
2023-05-17 2023-03-31 13F CONMED COM 207410101 0 -44 -100.00 0 -100.00
2023-03-06 2022-12-31 13F CONMED COM 207410101 44 -44 -50.00 3 -50.00 0.0000
2022-11-02 2022-09-30 13F CONMED COM 207410101 88 -29 -24.79 6 -40.00 0.0000
2022-08-12 2022-06-30 13F CONMED COM 207410101 117 23 24.47 10 -23.08 0.0001
2022-05-13 2022-03-31 13F CONMED COM 207410101 94 -66 -41.25 13 -38.10 0.0001
2022-02-14 2021-12-31 13F CONMED COM 207410101 160 125 357.14 21 600.00 0.0001
2021-11-12 2021-09-30 13F CONMED COM 207410101 35 20 133.33 3 50.00 0.0000
2021-08-10 2021-06-30 13F CONMED COM 207410101 15 6 66.67 2 100.00 0.0000
2021-05-11 2021-03-31 13F CONMED COM 207410101 9 9 1 0.0000
2019-11-12 2019-09-30 13F CONMED COM 207410101 0 -129 -100.00 0 -100.00
2019-08-09 2019-06-30 13F CONMED COM 207410101 129 129 11 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.